The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?

ABSTRACT:

SUBMITTER: Bitan G 

PROVIDER: S-EPMC7327354 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature